1-[2-(Piperazin-1-yl)ethyl]-2,5-dihydro-1H-pyrrole-2,5-dione dihydrochloride

Catalog No. :
ACUNKK685
CAS No. :
190714-38-6
Molecular Formula :
C10H17Cl2N3O2
Molecular Weight :
282.17

IUPAC Name:1-(2-(piperazin-1-yl)ethyl)-1H-pyrrole-2,5-dione dihydrochloride

1-[2-(Piperazin-1-yl)ethyl]-2,5-dihydro-1H-pyrrole-2,5-dione dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$340.00Login to see priceInquiryInquiry
250mg95%$477.00Login to see priceInquiryInquiry
1g95%$949.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-[2-(Piperazin-1-yl)ethyl]-2,5-dihydro-1H-pyrrole-2,5-dione dihydrochloride
IUPAC Name1-(2-(piperazin-1-yl)ethyl)-1H-pyrrole-2,5-dione dihydrochloride
MDL No.MFCD01075058
Molecular FormulaC10H17Cl2N3O2
Molecular Weight282.17
SMILESO=C(C=C1)N(CCN2CCNCC2)C1=O.[H]Cl.[H]Cl
InChI KeyHHNXNECFOKSRDW-UHFFFAOYSA-N
SynonymN-(2-PIPERAZINOETHYL)MALEIMIDE;1-(2-Maleimidoethyl)piperazine dihydrochloride;N-(2-Piperazinoethyl)maleimide dihydrochloride;1-[2-(piperazin-1-yl)ethyl]-2,5-dihydro-1H-pyrrole-2,5-dione dihydrochloride
CAS No.190714-38-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACUNKK685 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUNKK685 route product structure diagram
    ACUNKK685190714-38-6
Inquiry

2. ACUNKK685 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUNKK685 route product structure diagram
    ACUNKK685190714-38-6
Inquiry

Comments (0)